Cantech Letter

OS Therapies Provides First Half 2026 Corporate Outlook

OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...
EurekAlert!

New ALS drug stabilizes decline with a trend toward improved strength, mobility for some

Researchers from Washington University School of Medicine in St. Louis and collaborators report that long-term use of ...
Ethiopian News Agency on MSN

Ethio-Indian PhD mobility program that benefits over 1,000 Ethiopians launched

A PhD Mobility Program, which offers PhDs to more than 1,000 Ethiopian scholars in India or in joint supervision with Indian mentors in the coming five years, was launched today. The Ethio-Indian ...

OS Therapies Announces Successful Type C Meeting with US FDA Regarding Phase 2b Clinical ...

Detailed price information for Os Therapies Incorporated (OSTX-A) from The Globe and Mail including charting and trades.

OS Therapies Announces FDA PDUFA Waiver & EMA Grants Union Marketing Authorisation Eligibility

Detailed price information for Os Therapies Incorporated (OSTX-A) from The Globe and Mail including charting and trades.